Income Tax (Details 1) - USD ($) |
12 Months Ended | |
|---|---|---|
Aug. 31, 2023 |
Aug. 31, 2022 |
|
| Income Tax | ||
| Non-capital losses | $ 8,637,353 | $ 7,747,485 |
| Marketable securities | (14,051) | 0 |
| Stock based compensation | 650,778 | 0 |
| R&D | 371,326 | 0 |
| PPE and intangibles | (64,569) | 0 |
| Total deferred tax assets | 9,580,837 | 7,865,660 |
| Change in valuation allowance | (9,580,837) | (7,865,660) |
| Net Deferred tax assets | $ 0 | $ 0 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of net capital of broker-dealer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of paid and unpaid cash, stock, and paid-in-kind dividends declared for award under share-based payment arrangement. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of investment in marketable security. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|